万维提示：
1、该刊只有国际刊号。
2、投稿方式：官网投稿。
3、官网网址：
https://www.aimspress.com/journal/mmc
（主办单位官网信息）
4、投稿系统：
https://aimspress.jams.pub/login
5、主办单位相关网址：
http://www.qlshx.sdnu.edu.cn/info/10445/148044.htm
6、出刊日期：季刊，一年出版四期。
7、官网信息：不收版面费。
2025年12月19日星期五
Instruction for Authors
【官网信息】
1.Requirements
All submissions should be prepared with the following files, and submitted via JAMS, our online submission and peer-review system.
1.1. Cover letter, which may include:
• Concise summary of why your paper is a valuable addition to the scientific literature
• Brief relation of your study to previously published work
• Any recommended or opposed reviewers
• Confirmation from all authors that the manuscript will be considered for publication in AIMS Press journal in Open Access Format. It has not been published nor is it under consideration for publication elsewhere. Also confirm you have got the permission to reproduce the published materials in your manuscript.
• Referee reports if the paper was previously submitted to any of the AIMS journals at http://aimsciences.org/.
1.2. Full text, including Figures and Tables
2. Manuscript organization
2.1. File format
Authors should submit their manuscript files in Latex format.
Please add \usepackage[pagewise]{lineno}\linenumbers to the preamble, as a courtesy to referees who may wish to provide detailed feedback.
Template-MMC.zip
2.2. Manuscript length
Submissions to Mathematical Modelling and Control are expected to be no more than 10 pages in length in double-column format.
2.3. Title
• Titles should be concise and informative.
• Titles are to be in the sentence case. Meaning, only the first word and proper nouns are capitalized. If a theory,
formula, or specialized equation contains names (like Navier-Stokes) they are capitalized, otherwise leave them
lower case.
• Capitalization after a colon is required.
• Ensure the correct usage of articles. (a, an, the)
• Ensure the appropriate use of grammar and spelling.
More tips and suggestions can be found here.
Examples of titles done correctly:
“Optimal control of a stationary Navier-Stokes hemivariational inequality with numerical approximation”
“Global attractor of the Euler-Bernoulli equations with a localized nonlinear damping”
2.4. Authors and affiliations
All authors' full names (the middle name can be abbreviated) should be listed together and separated by commas. Link affiliations to the author's name with superscript numbers and list as follows: Laboratory, Department, Organization, City, State (in abbreviation if from USA , Canada , or Australia ), and Country.
The Corresponding Author should be marked with an asterisk, and their exact contact address, email address and telephone number should be listed in a separate paragraph. This information will be published with the article if accepted.
Any change of affiliation requests will not be allowed after publication. A note about the author's new address can be added to the article's webpage if needed.
If the article has been submitted on behalf of a consortium, all author names and affiliations should be listed at the end of the manuscript.
2.5. Headings and subheadings
There should be no more than 4 levels of headings. Capitalize only the first letter of the headings and subheadings.
2.6. Abstract and keywords
The abstract should:
• Describe the the context and purpose of the study
• Explain how the study was performed, including any model organisms used, without methodological detail
• Summarize the main findings and their significance
• Be less than 300 words
Please minimize the use of abbreviations (if possible) and do not cite references in the abstract.
No more than 5 keywords should be provided after the abstract in a separate paragraph.
2.7. Main text
The main text should include:
• Introduction
The Introduction section should provide a brief statement of the research background and whether the aim of the article was achieved.
• Materials and methods
The Materials and methods section should provide sufficient detail to allow suitably skilled investigators to repeat your study. This section should include the design of the study and the type of materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation if appropriate. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Materials and methods section.
If materials, methods, and protocols are well established, authors may cite articles where those protocols are described in detail, but the submission should include sufficient information to be understood independent of these.
For studies involving human participants, a statement detailing ethical approval and consent should be included in the methods section. For further details of the journal's editorial policies and ethical guidelines see “Specific Reporting Guidelines.”
• Results, Discussion, Conclusions
These sections may all be separate, or they may be combined to create a mixed Results/Discussion section (commonly labeled "Results and Discussion") or a mixed Discussion/Conclusions section (commonly labeled "Conclusions").
Authors should describe and explain the results of the experiments in these sections; they should explain how the results relate to the hypothesis presented as the basis of the study and provide a concise explanation of the implications of the findings, particularly in relation to previous related studies and potential future directions for research.
• Use of Generative-AI tools declaration
Here is our Guidelines for the Use of AI Tools in Writing and Research.
Instructions for declaring Generative-AI tools are at the end of the document.
• Acknowledgments (All sources of funding of the study must be disclosed)
If the research was funded, the author should list the funding information and grant number in the Acknowledgments section. If there are any contributions from other institutions or people, the author should acknowledge them in this section as well.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.
• Conflict of interest
The author should declare all relationships, financial, commercial or otherwise, that might be perceived by the academic community as representing a potential conflict of interest. If there are no such relationships, the author can state “All authors declare no conflicts of interest in this paper” in this section.
• References
All references, including URLs, must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Each reference must have an individual reference number. Please avoid excessive referencing. The references in the paper should be closely related to the paper. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission. We encourage the author to use Endnote or Reference Manager to prepare the references. Download the Endnote style file at AIMS style.ens
All citations in the text, figures or tables must be in the reference list and in numerical order; the citations should be called out in square brackets.
In references, the author should list the first 6 authors and use “et al.” to represent the other authors. The references should only include articles that are published or accepted. For accepted but unpublished works, use “in press” in place of page numbers. For material intended for publication but not yet accepted, use “unpublished work”or“submitted for publication”. Unpublished data or personal communications should be cited within the text only and not listed in the references.
References should be formatted as follows:
• Journal article style: Y. Benoist, P. Foulon, F. Labourie, Flots d’Anosov a distributions stable et instable differentiables, (French) [Anosov flows with stable and unstable differentiable distributions], J. Amer. Math. Soc., 5 (1992), 33–74.https://doi.org/10.1090/S0894-0347-1992-1124979-1
• Accepted, unpublished papers: Same as above, but “In press” appears instead of the page numbers.
• Book style : J. Serrin, Gradient estimates for solutions of nonlinear elliptic and parabolic equations, In: Zarantonello, E.Z. Author, Contributions to Nonlinear Functional Analysis, 2 Eds., New York: Academic Press, 1971. https://doi.org/10.1016/B978-0-12-775850-3.50017-0
• Online content: SARS Expert Committee, SARS in Hong Kong : From Experience to Action. Hong Kong SARS Expert Committee, 2003. Available from: http://www.sars-expertcom.gov.hk/english/reports/reports.html.
Cited journals should be abbreviated according to ISO 4 rules. For examples, see http://www.cas.org/expertise/cascontent/caplus/corejournals.html.
For more questions regarding reference style, please refer to Citing Medicine.
• Supplementary (if available and necessary)
We encourage authors to submit detailed supplementary, including dataset, document, image, video, software code, protocol, supporting information, table etc, but some large datasets (>100 MB) should be deposited in specialized service providers by author.
AIMS Press Open Data Policy is at here.
• Figures and tables
The following file formats are acceptable:
• EPS (.eps)
• PNG (.png)
• PDF (.pdf)
• JPEG (.jpg)
All figures should be in the RGB color mode, and be provided as separate files. Image resolution should be a minimum of 300 dpi.
If preparing the manuscript in Microsoft Word, use the table function to draw tables.
Authors should insert the Figures and Tables into the main text of the manuscript and call out all figures and tables in numerical order. There must be a caption under figure, and above table. Authors must obtain permission for the reuse of published materials from other sources.
2.8 License term and copyright
All articles published by AIMS Press are Open Access under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0). Under this license, authors retain ownership of the copyright for their content, and anyone can copy, distribute, or reuse these articles as long as the author and original source are properly cited.
3. English editing
3.1 English editing by AI language tools
Enhancing manuscript quality with Assistive-Artificial Intelligence (AI) language tools
At AIMS, we are committed to maintaining high language quality standards in all submitted manuscripts. To support our authors, we recommend the use of Assistive-AI language tools. These tools can significantly enhance the clarity, coherence, and overall quality of your writing. Below are three Assistive-AI tools that you may find particularly useful:
Grammarly
Grammarly is an advanced writing assistant that helps improve your writing by providing suggestions on grammar, spelling, punctuation, style, and tone. It also includes a plagiarism detection feature and vocabulary enhancement suggestions. Grammarly integrates seamlessly with various platforms, including Microsoft Word and Google Docs, making it a convenient tool for refining your manuscripts.
• Key features:
o Grammar and spelling check
o Style and tone suggestions
o Plagiarism detection
o Integration with multiple platforms
LanguageTool
LanguageTool is an open-source grammar and spell checker that supports over 20 languages. It identifies grammatical errors, spelling mistakes, and punctuation issues, offering suggestions for corrections. LanguageTool is especially beneficial for non-native English speakers and integrates with word processors like Microsoft Word and Google Docs.
• Key features:
o Grammar and spelling check
o Style suggestions
o Multilingual support
o Integration with multiple platforms
Curie
Curie is an AI writing assistant designed to enhance your writing by providing contextual grammar and style suggestions. It helps improve sentence structure, coherence, and readability. Curie also offers personalized feedback based on your writing style and integrates with various writing platforms.
• Key features:
o Contextual grammar and style suggestions
o Sentence structure and readability improvement
o Personalized feedback
o Integration with multiple writing platforms
We follow COPE's guidelines and policies regarding the use of AI tools: COPE Policy on AI tools.
Please disclose any Generative-AI use in your manuscript's “Use of Generative-AI tools declaration” portion at the end of your manuscript before the Acknowledgments section. (The tools listed above are not considered Generative-AI tools)
We encourage our authors to utilize these Assistive-AI tools to enhance the language quality of their manuscripts. Doing so will help ensure clarity, coherence, and a professional standard in your writing. This ultimately facilitates a smoother review and publication process and may increase the possibility of acceptance.
3.2 English editing by service providers
In order to speed up the peer review procedure, we encourage non-native English speaking authors to send their manuscript to a native English speaker or an English editing company for polishing before submitting to our journal. There are some English editing companies below for your consideration. Please provide the certification from the company you used along with the submission to our journal.
The code "AIMS" is active and can be used immediately. This will provide an ongoing 10% discount any time the author uses AJE services: English Language Editing, Manuscript Formatting, Figure Services, Translation.
It will provide a 10% discount for using Charlesworth services by enter the code “AIMSPress”.
4. Ethics approval of research
Methods sections of papers on research using human subject must include ethics statements that specify:
• The name of the approving institutional review board or equivalent committee(s). If approval was not obtained, the authors must provide a detailed statement explaining why it was not needed
• Whether informed consent was written or oral. If informed consent was oral, it must be stated in the manuscript:
• Why written consent could not be obtained
• That the Institutional Review Board (IRB) approved use of oral consent
• How oral consent was documented
For studies involving humans categorized by race/ethnicity, age, disease/disabilities, religion, sex/gender, sexual orientation, or other socially constructed groupings, authors should:
• Explicitly describe their methods of categorizing human populations
• Define categories in as much detail as the study protocol allows
• Justify their choices of definitions and categories, including, for example, whether any rules of human categorization were required by their funding agency
Methods sections of manuscripts reporting results of animal research must include required ethics statements that specify:
• The full name of the relevant ethics committee that approved the work, and the associated permit number(s) (where ethical approval is not required, the manuscript should include a clear statement of this and the reason why)
5. Clinical trial registration
Clinical trials must be pre-registered in a public trial registry. A list of acceptable registries can be found at https://www.who.int/clinical-trials-registry-platform and www.icmje.org. Authors can cite a reference to the registration in the Materials and methods section.
6. Cell line research
Methods sections for submissions reporting on research with cell lines should state the origin of any cell lines. For established cell lines, the provenance should be stated and references must also be given to either a published paper or to a commercial source. If previously unpublished de novo cell lines were used, including those gifted from another laboratory, details of institutional review board or ethics committee approval must be given, and confirmation of written informed consent must be provided if the line is of human origin.
